Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

11731-11740 of 13286 results

Catalogue Number:

HW627033

Category:

A

Anti-S100A5 Recombinant Antibody (N176A/35)

Target: S100A5
Target Alias Names: Protein S100-A5, S100A5, S100D, S100 calcium-binding protein A5, Protein S-100D
Species Reactivity: Other
Applications: Immunocytochemistry, Western Blot
Type: Primary Recombinant
Isotypes/Mimetics: IgG2a, kappa
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

YP926013

Category:

A

Anti-S1P/Sphingosine-1-phosphate Recombinant Antibody (SAA2035)

Target: S1P/Sphingosine-1-phosphate
Target Alias Names: S1P, Sphingosine-1-phosphateHuman Anti-S1P Recombinant Antibod SONEPCIZUMAB pleiotropic signaling lipid sphingosine-1-phosphate (S1P)A humanized monoclonal antibody directed against sphingosine 1-phosphate (S1P) with potential antiangiogenic and antineoplastic activities. Upon administration, sonepcizumab binds S1P, which may result in the inhibition of tumor angiogenesis. S1P is the extracellular ligand for the G protein-coupled lysophospholipid receptor EDG-1 (endothelial differentiation gene-1).
Species Reactivity: Other
Other Species Reactivity: General
Application: ELISA
Type: Primary Recombinant
Isotypes/Mimetics: IgG1, kappa
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

YP926016

Category:

A

Anti-S1P/Sphingosine-1-phosphate Reference Antibody (Sonepcizumab, RUO)

Target: S1PSphingosine-1-phosphate
Target Alias Names: S1P, Sphingosine-1-phosphate
Species Reactivity: Other
Other Species Reactivity: General
Applications: ELISA, Flow Cytometry
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

YP926026

Category:

A

Anti-S1P/Sphingosine-1-phosphate Reference Antibody (Sphingomab, RUO)

Target: S1P/Sphingosine-1-phosphate
Target Alias Names: S1P, Sphingosine-1-phosphate
Species Reactivity: Other
Other Species Reactivity: General
Applications: ELISA, Flow Cytometry
Type: Primary Recombinant
Isotypes/Mimetics: IgG1, kappa
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

AY373013

Category:

A

Anti-Sacituzumab Neutralizing Recombinant Antibody (SAA2983)

Target: Sacituzumab
Species Reactivity: Other
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

AY373023

Category:

A

Anti-Sacituzumab Neutralizing Recombinant Antibody (SAA2984)

Target: Sacituzumab
Species Reactivity: Other
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

AY373033

Category:

A

Anti-Sacituzumab Neutralizing Recombinant Antibody (SAA2985)

Target: Sacituzumab
Species Reactivity: Other
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

AY373043

Category:

A

Anti-Sacituzumab Neutralizing Recombinant Antibody (SAA2986)

Target: Sacituzumab
Species Reactivity: Other
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

VK585013

Category:

A

Anti-SADS-CoV Spike Recombinant Antibody (SAA2776)

Target: Spike
Target Alias Names: spike glycoprotein [Porcine enteric alphacoronavirus GDS04], S, N-terminal domain of the S1 subunit of coronavirus Spike (S) proteins, cl40465, SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV spike (S) glycoprotein from Rhinolophus bat coronavirus HKU2 and related alphacoronaviruses, cd22371, S1/S2 cleavage region, putative fusion peptide, internal fusion peptide, heptad repeat 1 [structural motif], heptad repeat 2 [structural motif]
Species Reactivity: Other
Other Species Reactivity: Porcine enteric alphacoronavirus GDS04
Applications: ELISA, Other
Type: Primary Recombinant
Isotype/Mimetic: IgG
Host Species: Human
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression

Catalogue Number:

ZA954013

Category:

A

Anti-Sahara scorpion AaH I/Neurotoxin I Recombinant Antibody (9C2)

Target: AaH I/Neurotoxin I
Target Alias Names: Alpha-mammal toxin AaH1, AaHI, Neurotoxin 1, Neurotoxin I
Species Reactivity: Other
Other Species Reactivity: Androctonus australis (Sahara scorpion)
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG2a
Host Species: Mouse
Formulation: Sodium-azide free, BSA-free, Carrier-free, Preservative-free, Glycerol-free, Low Endotoxin
Animal-Derived Biomaterials Used: No
Sequence Available No
Original Discovery Method Unknown
Antibody/Binder Origins: Animal-free discovery, In vitro recombinant expression